Vasoactive intestinal polypeptide binds with high affinity to non-small cell lung cancer cells and elevates cyclic AMP levels

This publication has 22 references indexed in Scilit:

• Absence of Immunoreactive Vasoactive Intestinal Polypeptide in Tissue from the Lungs of Patients with Asthma
  New England Journal of Medicine, 1989
• Inhibition of Growth of Human Lung Adenocarcinoma Cell Lines by Anti-Transforming Growth Factor- Monoclonal Antibody
  JNCI Journal of the National Cancer Institute, 1989
• Interaction of thymic peptide thymosin α1 with VIP receptors in rat intestinal epithelial cells: Comparison with PHI and secretin
  General Pharmacology: The Vascular System, 1989
• Characterization of Vasoactive Intestinal Peptide (VIP) receptors in mammalian lung
  Peptides, 1986
• Autoradiographic localisation of VIP receptors in human lung
  FEBS Letters, 1986
• Covalent cross‐linking of vasoactive intestinal peptide (VIP) to its receptor in intact colonic adenocarcinoma cells in culture (HT 29)
  European Journal of Biochemistry, 1985
• Activation of the cAMP-generating system by vasoactive intestinal polypeptide (VIP) in the human laryngeal malignant cell line HEp-2
  Bioscience Reports, 1984
• Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27
  Nature, 1983
• Presence of VIP receptors in a human pancreatic adenocarcinoma cell line. Modulation of the cAMP response during cell proliferation
  Biochemical and Biophysical Research Communications, 1983
• Comparison of VIP-secretin receptors in rat and human lung
  Peptides, 1981